Chief Executive Officer
CurrentPIC Therapeutics is focused on fundamentally changing how we treat cancer based on the modulation of RNA translation in unique ways. Our approach has the potential to become a next generation of cancer therapeutics, simultaneously modulating multiple oncogenic drivers by targeting a key nexus point of cancer signaling pathways.